566 related articles for article (PubMed ID: 20951870)
1. Influenza vaccines: the good, the bad, and the eggs.
Schultz-Cherry S; Jones JC
Adv Virus Res; 2010; 77():63-84. PubMed ID: 20951870
[TBL] [Abstract][Full Text] [Related]
2. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
Choo AY; Broderick KE; Kim JJ; Sardesai NY
IDrugs; 2010 Oct; 13(10):707-12. PubMed ID: 20878593
[TBL] [Abstract][Full Text] [Related]
3. Strategies for developing vaccines against H5N1 influenza A viruses.
Horimoto T; Kawaoka Y
Trends Mol Med; 2006 Nov; 12(11):506-14. PubMed ID: 17011235
[TBL] [Abstract][Full Text] [Related]
4. NEW technologies for meeting the global demand for pandemic influenza vaccines.
Fedson DS
Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
[TBL] [Abstract][Full Text] [Related]
5. The need for quadrivalent vaccine against seasonal influenza.
Belshe RB
Vaccine; 2010 Sep; 28 Suppl 4():D45-53. PubMed ID: 20713260
[TBL] [Abstract][Full Text] [Related]
6. Aerosol and nasal delivery of vaccines and antiviral drugs against seasonal and pandemic influenza.
Wong JP; Christopher ME; Viswanathan S; Schnell G; Dai X; Van Loon D; Stephen ER
Expert Rev Respir Med; 2010 Apr; 4(2):171-7. PubMed ID: 20406083
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.
Shi J; Wen Z; Guo J; Zhang Y; Deng G; Shu Y; Wang D; Jiang Y; Kawaoka Y; Bu Z; Chen H
Antiviral Res; 2012 Mar; 93(3):346-53. PubMed ID: 22281419
[TBL] [Abstract][Full Text] [Related]
8. Pandemic H5N1 influenza vaccine development: an update.
El Sahly HM; Keitel WA
Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
10. Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine?
Zijtregtop EA; Wilschut J; Koelma N; Van Delden JJ; Stolk RP; Van Steenbergen J; Broer J; Wolters B; Postma MJ; Hak E
Vaccine; 2009 Dec; 28(1):207-27. PubMed ID: 19800997
[TBL] [Abstract][Full Text] [Related]
11. New vaccine approaches for seasonal and pandemic influenza.
Palache B
Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
[TBL] [Abstract][Full Text] [Related]
12. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1241-5. PubMed ID: 19910912
[TBL] [Abstract][Full Text] [Related]
14. Current status and progress of prepandemic and pandemic influenza vaccine development.
Leroux-Roels I; Leroux-Roels G
Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
[TBL] [Abstract][Full Text] [Related]
15. Achieving clinical equality in an influenza pandemic: patent realities.
Kane EM
Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133
[TBL] [Abstract][Full Text] [Related]
16. Animal models for the preclinical evaluation of candidate influenza vaccines.
Bodewes R; Rimmelzwaan GF; Osterhaus AD
Expert Rev Vaccines; 2010 Jan; 9(1):59-72. PubMed ID: 20021306
[TBL] [Abstract][Full Text] [Related]
17. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
[TBL] [Abstract][Full Text] [Related]
18. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
19. Vaccination strategies to protect children against seasonal and pandemic influenza.
Rimmelzwaan GF; Bodewes R; Osterhaus AD
Vaccine; 2011 Oct; 29(43):7551-3. PubMed ID: 21820479
[TBL] [Abstract][Full Text] [Related]
20. Preparing for a possible pandemic: influenza A/H5N1 vaccine development.
Keitel WA; Atmar RL
Curr Opin Pharmacol; 2007 Oct; 7(5):484-90. PubMed ID: 17644429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
